Xia M - Search Results

1

FASN promotes lymph node metastasis in cervical cancer via cholesterol reprogramming and lymphangiogenesis.

Du Q, Liu P, Zhang C, Liu T, Wang W, Shang C, Wu J, Liao Y, Chen Y, Huang J, Tan H, Zhao Y, Xia M, Liu J, Yao S. Du Q, et al. Among authors: xia m. Cell Death Dis. 2022 May 21;13(5):488. doi: 10.1038/s41419-022-04926-2. Cell Death Dis. 2022. PMID: 35597782 Free PMC article.

2

Marine compound catunaregin inhibits angiogenesis through the modulation of phosphorylation of akt and eNOS in vivo and in vitro.

Liu JX, Luo MQ, Xia M, Wu Q, Long SM, Hu Y, Gao GC, Yao XL, He M, Su H, Luo XM, Yao SZ. Liu JX, et al. Among authors: xia m. Mar Drugs. 2014 May 12;12(5):2790-801. doi: 10.3390/md12052790. Mar Drugs. 2014. PMID: 24824025 Free PMC article.

3

Intravenous leiomyomatosis with intracardiac involvement.

Xia M, Liu J, Xiang X, Xu M, He M. Xia M, et al. Arch Gynecol Obstet. 2014 Sep;290(3):595-9. doi: 10.1007/s00404-014-3278-5. Epub 2014 May 20. Arch Gynecol Obstet. 2014. PMID: 24838291

4

TBLR1 is a novel prognostic marker and promotes epithelial-mesenchymal transition in cervical cancer.

Wang J, Ou J, Guo Y, Dai T, Li X, Liu J, Xia M, Liu L, He M. Wang J, et al. Among authors: xia m. Br J Cancer. 2014 Jul 8;111(1):112-24. doi: 10.1038/bjc.2014.278. Epub 2014 May 29. Br J Cancer. 2014. PMID: 24874481 Free PMC article. Clinical Trial.

5

CISD2 expression is a novel marker correlating with pelvic lymph node metastasis and prognosis in patients with early-stage cervical cancer.

Liu L, Xia M, Wang J, Zhang W, Zhang Y, He M. Liu L, et al. Among authors: xia m. Med Oncol. 2014 Sep;31(9):183. doi: 10.1007/s12032-014-0183-5. Epub 2014 Aug 20. Med Oncol. 2014. PMID: 25134919

6

Macrophage immigration inhibitory factor promotes cell proliferation and inhibits apoptosis of cervical adenocarcinoma.

Guo P, Wang J, Liu J, Xia M, Li W, He M. Guo P, et al. Among authors: xia m. Tumour Biol. 2015 Jul;36(7):5095-102. doi: 10.1007/s13277-015-3161-4. Epub 2015 Feb 26. Tumour Biol. 2015. PMID: 25716200

7

GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer.

Ouyang F, Liu J, Xia M, Lin C, Wu X, Ye L, Song L, Li J, Wang J, Guo P, He M. Ouyang F, et al. Among authors: xia m. Oncol Rep. 2017 May;37(5):2652-2662. doi: 10.3892/or.2017.5573. Epub 2017 Apr 11. Oncol Rep. 2017. PMID: 28405687 Free PMC article.

8

The prognostic value of Ki67 in ovarian high-grade serous carcinoma: an 11-year cohort study of Chinese patients.

Chen M, Yao S, Cao Q, Xia M, Liu J, He M. Chen M, et al. Among authors: xia m. Oncotarget. 2016 Dec 23;8(64):107877-107885. doi: 10.18632/oncotarget.14112. eCollection 2017 Dec 8. Oncotarget. 2016. PMID: 29296209 Free PMC article.

9

Fucosterol exhibits selective antitumor anticancer activity against HeLa human cervical cell line by inducing mitochondrial mediated apoptosis, cell cycle migration inhibition and downregulation of m-TOR/PI3K/Akt signalling pathway.

Jiang H, Li J, Chen A, Li Y, Xia M, Guo P, Yao S, Chen S. Jiang H, et al. Among authors: xia m. Oncol Lett. 2018 Mar;15(3):3458-3463. doi: 10.3892/ol.2018.7769. Epub 2018 Jan 10. Oncol Lett. 2018. Retraction in: Oncol Lett. 2022 Dec 01;25(1):32. doi: 10.3892/ol.2022.13618 PMID: 29456722 Free PMC article. Retracted.

10

Beliefs of Immunosuppressive Medication Among Chinese Renal Transplant Recipients, as Assessed in a Cross-Sectional Study With the Basel Assessment of Adherence to Immunosuppressive Medications Scale.

Xia M, Yan J, Liu S, Liu J. Xia M, et al. Transplant Proc. 2019 Apr;51(3):742-748. doi: 10.1016/j.transproceed.2018.10.029. Epub 2019 Jan 10. Transplant Proc. 2019. PMID: 30979459

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,663 results

Search Page

Filters